Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSafety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study.AuthorsHong, Ruoxi; Xia, Wen; Wang, Liye; Lee, Kaping; Lu, Qianyi; Jiang, Kuikui; Li, Shengfeng; Yu, Jinquan; Wei, Jin; Tang, Weijia; Zhou, Danyang; An, Xin; Huang, Jiajia; Xue, Cong; Bi, Xiwen; Shi, Yanxia; Yuan, Zhongyu; Xu, Fei; Wang, ShusenPublicationCancer Communications, 2021, Vol 41, Issue 2, p171ISSN2523-3548Publication typeArticleDOI10.1002/cac2.12135